Literature DB >> 29773550

CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up.

Helen Parker1, Neil Robert McIver-Brown2, Zadie A Davis2, Marina Parry1, Matthew J J Rose-Zerilli1, Aliki Xochelli3, Jane Gibson4, Renata Walewska1,2, Jonathan C Strefford1, David G Oscier1,2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29773550      PMCID： PMC5965055          DOI： 10.1182/bloodadvances.2018019760

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  21 in total

1.  Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.

Authors:  M M Corcoran; S J Mould; J A Orchard; R E Ibbotson; R M Chapman; A P Boright; C Platt; L C Tsui; S W Scherer; D G Oscier
Journal:  Oncogene       Date:  1999-11-04       Impact factor: 9.867

2.  Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).

Authors:  Christina Kalpadakis; Gerassimos A Pangalis; Theodoros P Vassilakopoulos; Maria Roumelioti; Sotirios Sachanas; Penelope Korkolopoulou; Efstathios Koulieris; Maria Moschogiannis; Xanthi Yiakoumis; Pantelis Tsirkinidis; Charalampos Pontikoglou; Dimitra Rondoyianni; Helen A Papadaki; Panayiotidis Panayiotidis; Maria K Angelopoulou
Journal:  Hematol Oncol       Date:  2016-10-13       Impact factor: 5.271

Review 3.  Clonal B-cell lymphocytosis of marginal zone origin.

Authors:  Aliki Xochelli; David Oscier; Kostas Stamatopoulos
Journal:  Best Pract Res Clin Haematol       Date:  2016-11-04       Impact factor: 3.020

4.  MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Authors:  Steven P Treon; Lian Xu; Guang Yang; Yangsheng Zhou; Xia Liu; Yang Cao; Patricia Sheehy; Robert J Manning; Christopher J Patterson; Christina Tripsas; Luca Arcaini; Geraldine S Pinkus; Scott J Rodig; Aliyah R Sohani; Nancy Lee Harris; Jason M Laramie; Donald A Skifter; Stephen E Lincoln; Zachary R Hunter
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

5.  Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations.

Authors:  Soraya Curiel-Olmo; Rufino Mondéjar; Carmen Almaraz; Manuela Mollejo; Laura Cereceda; Roso Marès; Sophia Derdak; Yolanda Campos-Martín; Ana Batlle; Sonia González de Villambrosía; Marta Gut; Julie Blanc; Alexandra Traverse-Glehen; Aurelie Verney; Lucile Baseggio; Francisca I Camacho; Andrew Wotherspoon; Kostas Stamatopoulos; Aliki Xochelli; Theodora Papadaki; George Kanellis; Maurilio Ponzoni; Monica García-Cosío; Jose P Vaqué; Sergi Beltrán; Ivo Gut; Miguel Angel Piris; Nerea Martínez
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

6.  Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features.

Authors:  Alessio Bruscaggin; Sara Monti; Luca Arcaini; Antonio Ramponi; Sara Rattotti; Marco Lucioni; Marco Paulli; Gianluca Gaidano; Davide Rossi
Journal:  Br J Haematol       Date:  2014-08-04       Impact factor: 6.998

7.  Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant.

Authors:  Emily F Mason; Ronald D Brown; David P Szeto; Christopher J Gibson; Yonghui Jia; Elizabeth P Garcia; Caron A Jacobson; Paola Dal Cin; Frank C Kuo; Geraldine S Pinkus; Neal I Lindeman; Lynette M Sholl; Jon C Aster; Elizabeth A Morgan
Journal:  Leuk Lymphoma       Date:  2016-05-31

8.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

9.  KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.

Authors:  A Clipson; M Wang; L de Leval; M Ashton-Key; A Wotherspoon; G Vassiliou; N Bolli; C Grove; S Moody; L Escudero-Ibarz; G Gundem; K Brugger; X Xue; E Mi; A Bench; M Scott; H Liu; G Follows; E F Robles; J A Martinez-Climent; D Oscier; A J Watkins; M-Q Du
Journal:  Leukemia       Date:  2014-11-27       Impact factor: 11.528

10.  The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.

Authors:  Davide Rossi; Vladimir Trifonov; Marco Fangazio; Alessio Bruscaggin; Silvia Rasi; Valeria Spina; Sara Monti; Tiziana Vaisitti; Francesca Arruga; Rosella Famà; Carmela Ciardullo; Mariangela Greco; Stefania Cresta; Daniela Piranda; Antony Holmes; Giulia Fabbri; Monica Messina; Andrea Rinaldi; Jiguang Wang; Claudio Agostinelli; Pier Paolo Piccaluga; Marco Lucioni; Fabrizio Tabbò; Roberto Serra; Silvia Franceschetti; Clara Deambrogi; Giulia Daniele; Valter Gattei; Roberto Marasca; Fabio Facchetti; Luca Arcaini; Giorgio Inghirami; Francesco Bertoni; Stefano A Pileri; Silvia Deaglio; Robin Foà; Riccardo Dalla-Favera; Laura Pasqualucci; Raul Rabadan; Gianluca Gaidano
Journal:  J Exp Med       Date:  2012-08-13       Impact factor: 14.307
View more
  1 in total

1.  Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma.

Authors:  Carolina Jaramillo Oquendo; Helen Parker; David Oscier; Sarah Ennis; Jane Gibson; Jonathan C Strefford
Journal:  Sci Rep       Date:  2019-07-18       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.